|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0150 CAD | 0.00% |
|
0.00% | -75.00% |
| 04-02 | RAMM Pharma Corp. Reports Earnings Results for the First Quarter Ended January 31, 2026 | CI |
| 03-05 | RAMM Pharma Corp. Reports Earnings Results for the Full Year Ended October 31, 2025 | CI |
| Market Cap | 1.79M 1.26M 1.1M 1.02M 954K 119M 1.8M 12.15M 4.73M 58.75M 4.75M 4.64M 204M | P/E 2024 |
-0.07x | P/E 2025 | -0.2x |
|---|---|---|---|---|---|
| Enterprise Value | 1.07M 754K 659K 609K 569K 71.22M 1.08M 7.24M 2.82M 35.02M 2.83M 2.77M 122M | EV / Sales 2024 |
0.13x | EV / Sales 2025 | 0.32x |
| Free-Float |
68.57% | Yield 2024 * |
-
| Yield 2025 | - |
| 6 months | -62.50% | ||
| Current year | -75.00% |
| 1 month | 0.01 | 0.02 | |
| Current year | 0.01 | 0.05 | |
| 1 year | 0.01 | 0.25 | |
| 3 years | 0 | 0.25 | |
| 5 years | 0 | 1 | |
| 10 years | 0 | 1.19 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jackie Burnett
CEO | Chief Executive Officer | - | 30/09/2019 |
José Roldan
DFI | Director of Finance/CFO | - | 08/12/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Jackie Burnett
BRD | Director/Board Member | - | 30/09/2019 |
Daniel Augereau
BRD | Director/Board Member | 82 | 30/09/2019 |
Eric Klein
BRD | Director/Board Member | 66 | 30/09/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01/06/25 | Sell | Chief Executive Officer | 4,667,000 | 3.9091% | ||
| 20/03/25 | Buy | Chief Executive Officer | 200,000 | 0.1675% | ||
| 20/03/25 | Buy | Chief Executive Officer | 100,000 | 0.0838% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | +50.00% | -70.00% | 1.26M | ||
| +0.32% | -2.73% | +44.49% | +143.28% | 980B | ||
| +1.27% | -3.98% | +54.41% | +41.13% | 550B | ||
| +6.25% | +1.00% | +24.13% | +68.06% | 382B | ||
| -0.06% | -3.09% | +23.33% | +16.78% | 316B | ||
| +0.42% | -1.28% | +27.89% | +14.71% | 272B | ||
| +1.67% | -1.47% | +26.76% | +32.88% | 268B | ||
| +2.39% | +4.42% | -36.96% | -45.12% | 199B | ||
| +2.11% | -2.95% | +19.14% | +51.83% | 182B | ||
| +0.90% | -0.57% | +15.09% | +60.89% | 154B | ||
| Average | +1.54% | -2.43% | +24.83% | +31.44% | 330.23B | |
| Weighted average by Cap. | +1.52% | -3.50% | +31.28% | +65.69% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 4.34M 3.07M 2.68M 2.48M 2.31M 290M 4.37M 29.45M 11.46M 142M 11.51M 11.26M 495M | 3.36M 2.37M 2.07M 1.92M 1.79M 224M 3.39M 22.79M 8.87M 110M 8.91M 8.72M 383M |
| Net income | -16.5M -11.65M -10.18M -9.42M -8.79M -1.1B -16.62M -112M -43.55M -541M -43.75M -42.8M -1.88B | -8.91M -6.29M -5.5M -5.09M -4.75M -595M -8.98M -60.43M -23.51M -292M -23.62M -23.11M -1.02B |
| Net Debt | -626K -442K -386K -357K -333K -41.75M -630K -4.24M -1.65M -20.53M -1.66M -1.62M -71.32M | -723K -511K -446K -413K -385K -48.28M -729K -4.91M -1.91M -23.74M -1.92M -1.88M -82.46M |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- RAMM Stock
Select your edition
All financial news and data tailored to specific country editions
















